首页> 外文期刊>European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) >Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.
【24h】

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer.

机译:前哨淋巴结中调节性T细胞的积累是淋巴结阴性乳腺癌患者的预后指标。

获取原文
获取原文并翻译 | 示例
           

摘要

It has been revealed that sentinel lymph nodes (SLNs) from patients with node-negative breast cancer involve RT-PCR detected micrometastases and isolated tumour cells. However, the prognostic significance of the pathologically undetectable micrometastases is still controversial. In this study, we evaluated Foxp3 positive regulatory T cells (Treg) in SLNs as host-side immune marker that has the potential to detect these micrometastases. In the analyses of training set (n=30), elevated Treg was strongly associated with the pathologically undetectable micrometastases. In the analyses of validation set (n=129) in patients with node-negative, relapse-free survival in patients with elevated Treg was significantly shorter than those with lower Treg (p=0.005). Furthermore, in multivariate analyses, elevated Treg was correlated with relapse-free survival (p=0.012). Our data indicate that Treg may increase in the microenvironment of SLNs along with pathologically undetectable micrometastases and is a prognostic predictor in patients with node-negative breast cancer.
机译:已经发现来自淋巴结阴性乳腺癌患者的前哨淋巴结(SLN)涉及RT-PCR检测到的微转移和分离的肿瘤细胞。然而,病理学上无法检测到的微转移的预后意义仍然存在争议。在这项研究中,我们评估了SLNs中Foxp3阳性调节性T细胞(Treg)作为宿主侧免疫标志物的潜力,可以检测这些微转移。在训练集(n = 30)的分析中,Treg升高与病理学上无法检测到的微转移密切相关。在淋巴结阴性患者的验证集(n = 129)分析中,Treg升高的患者的无复发生存期明显短于Treg降低的患者(p = 0.005)。此外,在多变量分析中,升高的Treg与无复发生存相关(p = 0.012)。我们的数据表明,Treg可能在SLNs的微环境中增加,并且在病理学上无法检测到微转移,并且是淋巴结阴性乳腺癌患者的预后指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号